262
Participants
Start Date
September 30, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
December 31, 2013
solifenacin 5mg, 10mg
solifenacin 5mg, 10mg
Asan Medical Center, Seoul
Lead Sponsor
Samsung Medical Center
OTHER
Seoul National University Hospital
OTHER
The Catholic University of Korea
OTHER
Ajou University
OTHER
Severance Hospital
OTHER
Cheil General Hospital and Women's Healthcare Center
OTHER
SMG-SNU Boramae Medical Center
OTHER
Pusan National University Yangsan Hospital
OTHER
Asan Medical Center
OTHER